The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase I study of radiotherapy (RT) & durvalumab in relapsed/refractory diffuse large B-cell lymphoma (DLBCL) & follicular lymphoma (FL): The RADD study.
 
Eliza Anne Hawkes
Consulting or Advisory Role - AstraZeneca; Gilead Sciences (Inst); Merck Sharpe & Dohme (Inst); Roche/Genentech (Inst)
Speakers' Bureau - Roche/Genentech (Inst)
Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Gilead Sciences (Inst); Janssen-Cilag (Inst); Merck KGaA (Inst); Mundipharma (Inst)
Travel, Accommodations, Expenses - Roche/Genentech
 
Kate Manos
Travel, Accommodations, Expenses - Bristol-Myers Squibb
 
Geoffrey Chong
Research Funding - AstraZeneca (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Hutchison MediPharma (Inst); Isofol Medical (Inst); Merck Serono (Inst); Pharmacyclics (Inst); Regeneron (Inst)
 
Jodie Palmer
Stock and Other Ownership Interests - Avecho
 
Michael Patrick MacManus
Research Funding - Lilly (Inst)
 
Colm Keane
Honoraria - Celgene; Gilead Sciences; MSD Oncology; Roche
Consulting or Advisory Role - Celgene; Gilead Sciences; Janssen; MSD Oncology; Roche
Speakers' Bureau - Gilead Sciences; Roche
Research Funding - Bristol-Myers Squibb (Inst)
Travel, Accommodations, Expenses - Celgene; Gilead Sciences; MSD Oncology; Roche
 
Andrew Mark Scott
Stock and Other Ownership Interests - Life Science Pharmaceuticals; Paracrine Therapeutics
Consulting or Advisory Role - Life Science Pharmaceuticals
Research Funding - Abbvie (Inst); AstraZeneca (Inst); Celgene (Inst); EMD Serono (Inst); Isotopen Technologien (Inst); MedImmune (Inst); Merck (Inst); Telix Pharmaceuticals (Inst)
Patents, Royalties, Other Intellectual Property - Abbvie; Humanigen; Limos Therapeutics; Ludwig Institute for Cancer Research; Paracrine Therapeutics
Travel, Accommodations, Expenses - MedImmune
 
Jake Shortt
Consulting or Advisory Role - Bristol-Myers Squibb; Celgene; Novartis
Speakers' Bureau - Bristol-Myers Squibb; Celgene; Gilead Sciences; Takeda
Research Funding - Amgen; Astex Pharmaceuticals
Travel, Accommodations, Expenses - BMS Brazil
 
David Ritchie
Honoraria - Amgen; Novartis; Sanofi
Consulting or Advisory Role - Amgen; Pfizer
Research Funding - Amgen; BeiGene; Bristol-Myers Squibb; Imago Pharma; Takeda
 
Leonid Churilov
Employment - Healthscope Advanced Pathology
 
Laura Johnston
No Relationships to Disclose
 
Tom Witkowski
No Relationships to Disclose
 
Allison Anne Barraclough
No Relationships to Disclose
 
Sze Ting Lee
No Relationships to Disclose
 
Wendi Lin
No Relationships to Disclose
 
Rachel Koldej
No Relationships to Disclose
 
Richard Khor
Honoraria - Elekta
Travel, Accommodations, Expenses - Elekta